ZTE Issues Update on Global Patent Invalidation Action Against Vringo
ZTE Corporation announced that the Patent Re-examination Board of the State
Intellectual Property Office of the People's Republic of China is reviewing
applications from the company to invalidate 32 patents claimed by Vringo Inc. (NASDAQ: VRNG)
and its subsidiaries.
Further applications to invalidate the patents claimed by Vringo entities will
be filed by ZTE to the Patent Re-examination Board. ZTE has also initiated
patent invalidation litigations against Vringo in courts in the United
Kingdom, Germany and Australia.
ZTE reserves the right to pursue further action in other jurisdictions to
protect the interests of the company and our customers.
ZTE is committed to defending the company and our subsidiaries against
patent-related claims initiated by Vringo entities in litigations in Europe,
Asia and South America. ZTE steadfastly opposes all forms of abuses of
intellectual property, and the improper use of patent assets as a tactic in
In parallel to the concerted global patent invalidation action, ZTE has filed
an antitrust complaint with the European Commission, requesting the regulator
to investigate the licensing practices of Vringo in light of concerns that
these practices are impeding fair competition in the telecommunications
According to the World Intellectual Property Organization, ZTE submitted 2,309
filings under the Patent Cooperation Treaty in 2013, the second-highest total
globally. ZTE ranked top in the WIPO's PCT application tables in 2011 and
2012, reflecting the company's world-leading efforts in technology innovation.
In the past five years, ZTE has invested more than RMB 40 billion in research
and development. As of the end of 2013, more than 16,000 patents have been
granted to ZTE. The world-leading intellectual property assets of ZTE offer a
strong safeguard for the company to prevail in patent litigations
Since December 2013, courts in the United States issued rulings in favor of
ZTE in at least three cases concerning Section 337 of the Tariff Act of 1930.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.